Aspira Pathlab & Diagnostics Ltd.BSE: ASPIRA

Aspira Pathlab & Diagnostics Ltd. Press Release Apr 10 2026

· Issued by Aspira Pathlab & Diagnostics Ltd. via BSE India

Filed with BSE ·

Aftertrade Broking Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendation of the Independent Director Committee ('IDC') in relation to the Open Offer ('Offer') to the Public Shareholders of the Aspira Pathlab & Diagnostics Ltd ("Target Company") under Regulations 26(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and Subsequent Amendments thereto ('SEBI (SAST) Regulations, 2011').
.

View Attachment

6ix hasn’t read this filing yet.

Aspira Pathlab & Diagnostics Ltd. on 6ix

Earlier from Aspira Pathlab & Diagnostics

Later from Aspira Pathlab & Diagnostics

All Aspira Pathlab & Diagnostics news releases